ARTICLE | Clinical News
GTx begins Phase prostate cancer IIb/III
October 23, 2001 7:00 AM UTC
GTx (Memphis, Tenn.) began a double-blind, placebo-controlled U.S. Phase IIb/III trial of its Acapodene toremifene non-steroidal antiestrogen to prevent prostate cancer. The study in 500 patients with...